2011-09-06 03:05:16 - New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

Risperdal (Schizophrenia) - Analysis and Forecasts to 2020

Summary

GlobalData's pharmaceuticals report, "Risperdal (Schizophrenia) - Analysis and Forecasts to 2020" provides Risperdal sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2003-2020). The report also includes information on Schizophrenia market. This report is built using data and information sourced from GlobalData's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.


Full Report Details at
-

www.fastmr.com/prod/217565_risperdal_schizophrenia_analysis_and_ ..


Scope

* Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
* Analysis and review of Risperdal Consta including historical sales data
* Qualitative and quantitative assessment of market space
* Analysis of the trends, drivers and restraints shaping and defining the markets
* In-depth analysis of Risperdal Consta including efficacy, safety, pricing, competition and other details which influence its sales potential
* Detailed sales forecast for 2003-2020 for Risperdal Consta in each of the seven major markets

Reasons to buy

* Understand and capitalize by identifying products that are most likely to ensure a robust return
* Stay ahead of competition by understanding the changing competitive landscape
* Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
* Make more informed business decisions from insightful and in-depth analysis of the drug's performance
* Examine the historical sales performance of a drug in seven major markets
* Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets


Partial Table of Contents:

1 Risperdal Consta - Analysis and Forecasts from 2003 to 2020
2 Table of contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Schizophrenia
3.2 Symptoms
3.3 Schizophrenia Market
3.4 Epidemiology
3.5 Etiology
3.5.1 Genetic Factors
3.5.2 Environmental Factors
3.5.3 Abnormal Brain Structure
3.6 GlobalData Report Guidance
4 Schizophrenia: Market Characterization
4.1 Schizophrenia Market
4.2 Schizophrenia Market Forecasts and CAGR
4.3 Drivers of Schizophrenia Therapeutics Market
4.3.1 Patent Expiry of Leading Marketed Drugs
4.3.2 Increasing Patient Pool
4.3.3 High Prescription Rates
4.3.4 Low Patient Compliance Rate
4.3.5 High Unmet Need
5 Classification of Schizophrenia
5.1 Age of Onset of Schizophrenia
5.1.1 Pediatric / Adolescent / Childhood Schizophrenia
5.1.2 Adult Schizophrenia
5.2 Associated Symptoms
5.2.1 Paranoid Schizophrenia
5.2.2 Disorganized Schizophrenia
5.2.3 Catatonic Schizophrenia
5.2.4 Residual Schizophrenia
5.2.5 Undifferentiated Disorder
6 Treatment for Schizophrenia
6.1 Crisis Resolution Teams (CRT)
6.2 Voluntary and Compulsory Detention
6.3 Antipsychotics
7 Risperdal Consta
7.1 Introduction
7.2 Mechanism of Action
7.3 Clinical Studies
7.4 Launch History
7.5 Factors Affecting Sales of Risperdal Consta
7.5.1 Risperdal Consta Associated with Lower Risk of Hospitalization
7.5.2 Risperdal Consta (Long-acting injection (RLAI)
7.5.3 Treatment of Schizophrenia in Adults and Adolescents
7.5.4 Risperdal versus Risperdal Consta
7.6 Drug Evaluation
7.6.1 Drug Risk Benefit Score
7.6.2 Intensity of Competition
7.7 Sales forecast
7.7.1 Target Patient Pool of Risperdal Consta
7.7.2 Dosing
7.7.3 Market Penetration
7.7.4 Annual Cost of Therapy
7.7.5 Sales Projections of Risperdal Consta
8 Schizophrenia Market: Appendix
8.1 Market Definitions
8.2 Abbreviations
8.3 Research Methodology
8.4 Contact Us
8.5 Disclaimer
8.6 Sources

List of Tables

1.1 List of Tables
Table 1: Schizophrenia, Global, Market Size Forecasts ($bn), 2010-2020
Table 2: 12-week, Double-blind, Randomized, Placebo Controlled Trial, Risperdal Consta
Table 3: LaunchHistory of Risperdal Consta
Table 4: Drug Risk Benefit Score of Risperdal Consta
Table 5: Efficacy Results
Table 6: Risperdal Consta, Schizophrenia, Global, Estimated Sales ($m), 2003-2020
Table 7: Risperdal Consta, Schizophrenia, The US, Estimated Sales ($m), 2003-2020
Table 8: Risperdal Consta, Schizophrenia, The UK, Estimated Sales ($m), 2003-2020
Table 9: Risperdal Consta, Schizophrenia, France, Estimated Sales ($m), 2005-2020
Table 10: Risperdal Consta, Schizophrenia, Germany, Estimated Sales ($m), 2003-2020
Table 11: Risperdal Consta, Schizophrenia, Italy, Estimated Sales ($m), 2005-2020
Table 12: Risperdal Consta, Schizophrenia, Spain, Estimated Sales ($m), 2004-2020
Table 13: Risperdal Consta, Schizophrenia, Japan, Estimated Sales ($m), 2009-2020

List of Figures

1.2 List of Figures
Figure 1: Risk of Developing Schizophrenia
Figure 2: Environmental Factors in the Development of Schizophrenia

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=217565&dt=t

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.